Okada, M Sakamoto Hospital
Bando, Hiroshi Sakamoto Hospital|Tokushima University|Japan Low Carbohydrate Diet Promotion Association KAKEN Search Researchers
Iwatsuki, N Sakamoto Hospital
Ogawa, T Sakamoto Hospital
Sakamoto, K Sakamoto Hospital
Trial for Imeglimin Efficacy and Safety (TIMES)
Background: Oral semaglutide (imeglimin) has been prescribed for patients with type 2 diabetes (T2D) as Twymeeg.
Case presentation: The patient is 77-year-old male with hypertension, previous cerebral vascular accident (CVA). He continued unbalanced meal with preference of much carbohydrate. In Sept 2021, he became diabetic with HbA1c 8.8%.
Results: Imeglimin 2000mg/day was started improving to 6.7% for 2 months.
Discussion: Complete blood count (CBC) showed decreased Hb and increased MCV, suggesting macrocytic anemia for lack of vegetables. Much carbohydrate intake may bring T2D. Remarkable diabetic improvement may be from dual mechanisms for increasing insulin secretion and decreasing insulin resistance.
SunText Review of Medical & Clinical Research
This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
|DOI (Published Version)|
|URL ( Publisher's Version )|
srmcr_3_2_155.pdf 432 KB